Drugs / BIIB028
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00725933 | Jun 2008 → Oct 2011 | cancer | Biogen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIIB028 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00725933 ↗ |
| Modality | Small molecule | — CHEMBL4297359 ↗ |
| Route | Intravenous | “IV infusion administered twice weekly” NCT00725933 ↗ |